HIV and ID Observations

November 12th, 2021

Time to Simplify the COVID-19 Vaccine Policy — Authorize a Booster Dose for Anyone Who Wants One

At this point in the post-vaccine era of the pandemic, we all know people who have had COVID-19 despite being fully vaccinated. Patients, coworkers, family, friends. The reason these breakthroughs are so common is now obvious — our initial vaccine strategies did not provide durable protection against infection. And recognition of this fact prompted the FDA […]

---

October 31st, 2021

Interesting and Important Studies from IAS 2021 and IDWeek That Caught My Eye

As noted in my previous post, attending virtual meetings poses some serious challenges. The biggest obstacle:  trying to do one’s regular job while periodically checking in (or more likely not checking in) on the meeting. And while I might have been able to pull off some Really Rapid Reviews© after a few virtual meetings, not so […]

---

October 1st, 2021

A Thank You to One of Our Best Patient-Teachers

Harvard Medical School and Brigham and Women’s Hospital lost one of their best teachers this week. No, it wasn’t a distinguished professor or astute clinician. It was one of my long-term patients, who had given himself selflessly to teach dozens of medical students, residents, and (especially) ID fellows over the nearly 30 years I’d known him. Let’s […]

---

August 2nd, 2021

Provincetown July Celebration a Challenging Stress Test for the COVID-19 Vaccines

When the complete history of the COVID-19 pandemic is eventually written — and boy oh boy, can’t wait for that — certain events will feature prominently as sites of notable outbreaks. The Diamond Princess cruise ship The Biogen Leadership conference The Skagit Valley Chorale practice The Sturgis motorcycle rally The Amy Coney Barrett White House reception And now: The Provincetown Independence Week celebration […]

---

July 1st, 2021

Five Reasons Why ID Doctors Are the Paperwork Champs

As they often do, the inquisitive folks over at Medscape polled doctors around the country on various topics. This one hit home: We're #1! https://t.co/4peKM1frWx pic.twitter.com/wwCrcXBrVI — Paul Sax (@PaulSaxMD) June 17, 2021 Say what you will about Medscape’s methodology, or representativeness, or need for statistical analysis. But we’re clearly #1 in the Paperwork and Administration category — and […]

---

June 1st, 2021

We’re Allowed to Say that Some COVID-19 Vaccines Are Better than Others, Right?

Over on the CDC website, an amazing resource, there’s this statement about the COVID-19 vaccines: The best COVID-19 vaccine is the first one that is available to you. Do not wait for a specific brand. I certainly agreed with that comment back in late 2020 and early 2021, when demand for vaccines exceeded supply, and we […]

---

April 25th, 2021

The Decision on the Johnson & Johnson COVID-19 Vaccine Surprised Me — Here’s Why

The “pause” on the one-shot Johnson & Johnson (J&J) COVID-19 vaccine is over. Based on a further review of safety data that occurred on April 23, both the CDC and the FDA said the vaccine may resume here in the U.S., provided the label includes a warning about a serious, but rare, side effect — […]

---

February 7th, 2021

Does Taking Vitamin D Prevent or Treat COVID-19?

Vitamin D supplementation — critical in prevention and treatment of COVID-19? Or does it do nothing — except further enrich the vitamin and supplements industry, which is worth more than 100 billion dollars? The challenge is figuring out which of these is the truth, and after several weeks of thinking about the issue, I find it’s far […]

---

January 11th, 2021

After Ivermectin Controversy, A COVID-19-Free ID Link-o-Rama

Wow, quite the week for this country of ours. We’re all deeply saddened by the events, very hopeful that the transition in leadership will be peaceful. And also an eventful week for this little blog. When I wrote “Enter ivermectin — and let the controversy begin,” little did I know. Amazingly, this is already the second-most widely […]

---

January 4th, 2021

Ivermectin for COVID-19 — Breakthrough Treatment or Hydroxychloroquine Redux?

It’s an indisputable fact that we need better treatments for COVID-19. This is particularly true in the outpatient setting. Let’s count how many we have today, hmm, this shouldn’t take long. That would be zero — the same number we had over a year ago, when the disease first emerged in China. Something safe, easy to take […]

---